Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge Acted as Advisors in the Sale of Convatech
Mandate

Vinge Acted as Advisors in the Sale of Convatech

May 07, 2008

Vinge advised Bristol-Mayers in the sale of the American company Convatec to Nordic Capital and Avista. The purchase price for Convatec was SEK 25 billion.

Vinge acted as advisors within the part of the transaction that was joined to Sweden. Vinge’s team included Christina Kokko, Peter Larsson, Johan Larsson, Björn Lindskog and Niclas Bergström.

Related

Vinge has advised Oncopeptides in connection with a directed share issue

 Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

 Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

 Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026